Destabilizing Domains Mediate Reversible Transgene Expression in the Brain

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Tai, Khalid ^a   Quintino, Luis ^a   Isaksson, Christina ^a   Gussing, Fredrik ^a   Lundberg, Cecilia ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HYBRID PROTEIN; LENTIVIRUS VECTOR; TRIMETHOPRIM; YELLOW FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DESTABILIZING DOMAIN; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE THERAPY; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; TRANSGENE; UPREGULATION;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BRAIN; CELL LINE, TUMOR; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; INJECTIONS, INTRAVENTRICULAR; LENTIVIRUS; LUMINESCENT PROTEINS; MODELS, ANIMAL; MOLECULAR TARGETED THERAPY; PARKINSON DISEASE; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; TETRAHYDROFOLATE DEHYDROGENASE; TRANSGENES; TRIMETHOPRIM;

ESCHERICHIA COLI;

EID: 84866995180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046269     Document Type: Article

References (25)

1. Cress DE, (2008) The need for regulatable vectors for gene therapy for Parkinson's disease. Exp Neurol 209: 30-33.
2. Kordower JH, Olanow CW, (2008) Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself? Exp Neurol 209: 34-40.
3. Guo ZS, Li Q, Bartlett DL, Yang JY, Fang B, (2008) Gene transfer: the challenge of regulated gene expression. Trends Mol Med 14: 410-418.
4. Stieger K, Belbellaa B, Le Guiner C, Moullier P, Rolling F, (2009) In vivo gene regulation using tetracycline-regulatable systems. Adv Drug Deliv Rev 61: 527-541.
5. Pollock R, Issner R, Zoller K, Natesan S, Rivera VM, et al. (2000) Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc Natl Acad Sci U S A 97: 13221-13226.
6. Georgievska B, Jakobsson J, Persson E, Ericson C, Kirik D, et al. (2004) Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Hum Gene Ther 15: 934-944.
7. Ginhoux F, Turbant S, Gross DA, Poupiot J, Marais T, et al. (2004) HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol Ther 10: 279-289.
8. Szulc J, Aebischer P, (2008) Conditional gene expression and knockdown using lentivirus vectors encoding shRNA. Methods Mol Biol 434: 291-309.
9. Vogel R, Mammeri H, Mallet J, (2008) Lentiviral vectors mediate nonimmunosuppressive rapamycin analog-induced production of secreted therapeutic factors in the brain: regulation at the level of transcription and exocytosis. Hum Gene Ther 19: 167-178.
10. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
11. Banaszynski LA, Chen LC, Maynard-Smith LA, Ooi AG, Wandless TJ, (2006) A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126: 995-1004.
12. Banaszynski LA, Sellmyer MA, Contag CH, Wandless TJ, Thorne SH, (2008) Chemical control of protein stability and function in living mice. Nat Med 14: 1123-1127.
13. Iwamoto M, Bjorklund T, Lundberg C, Kirik D, Wandless TJ, (2010) A general chemical method to regulate protein stability in the mammalian central nervous system. Chem Biol 17: 981-988.
14. Barling RW, Selkon JB, (1978) The penetration of antibiotics into cerebrospinal fluid and brain tissue. J Antimicrob Chemother 4: 203-227.
15. Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH, (2010) Neurotrophic factor therapy for Parkinson's disease. Progress in brain research 184: 237-264.
16. Suter DM, Dubois-Dauphin M, Krause KH, (2006) Genetic engineering of embryonic stem cells. Swiss Med Wkly 136: 413-415.
17. Nielsen TT, Marion I, Hasholt L, Lundberg C, (2009) Neuron-specific RNA interference using lentiviral vectors. J Gene Med 11: 559-569.
18. Xiao H, Hirata Y, Isobe K, Kiuchi K, (2002) Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines. Journal of neurochemistry 82: 801-808.
19. Regulier E, Pereira de Almeida L, Sommer B, Aebischer P, Deglon N, (2002) Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum Gene Ther 13: 1981-1990.
20. Aebischer P, Ridet J, (2001) Recombinant proteins for neurodegenerative diseases: the delivery issue. Trends Neurosci 24: 533-540.
21. Rang H, Dale M, Ritter J, Moore P (2003) Pharmacology. London: Churchill Livingstone.
22. Anderson PO, Knoben JE, Troutman WG (2001) Handbook of Clinical Drug Data: McGraw-Hill.
23. Rungoe C, Malchau EL, Larsen LN, Schroeder H, (2010) Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis. Pediatr Blood Cancer 55: 304-308.
24. Zywiel MG, Johnson AJ, Stroh DA, Martin J, Marker DR, et al. (2010) Prophylactic oral antibiotics reduce reinfection rates following two-stage revision total knee arthroplasty. Int Orthop 35: 37-42.
25. Arvidsson A, Kirik D, Lundberg C, Mandel RJ, Andsberg G, et al. (2003) Elevated GDNF levels following viral vector-mediated gene transfer can increase neuronal death after stroke in rats. Neurobiol Dis 14: 542-556.